Statistically developed docetaxel-laden mixed micelles for improved therapy of breast cancer

Statistically developed docetaxel-laden mixed micelles for improved therapy of breast cancer

Docetaxel (DTX) has poor solubility, serious side effects, and multi-drug resistance (MDR) limiting its use in cancer treatment. Hence, the present study aimed to formulate and develop docetaxel mixed micelles (DTX MMs) for breast cancer treatment. DTX MMs were prepared from a mixture of docetaxel,...

Full description

Bibliographic Details
Main Authors: Smita S. Patil, Rutuja D. Chougale, Arehalli S. Manjappa, John I. Disouza, Ashok A. Hajare, Kiran S. Patil
Format: Article
Language:English
Published: Elsevier 2022-11-01
Series:OpenNano
Subjects:
Docetaxel
Mixed micelles
Poloxamer 188
TPGS
Breast cancer
Cytotoxicity study
Online Access:http://www.sciencedirect.com/science/article/pii/S235295202200041X

Internet

http://www.sciencedirect.com/science/article/pii/S235295202200041X

Similar Items